News
December 13, 2024

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

Regenstrief one of the partners expected to drive advancements and commercialization in biosciences 

Regenstrief Institute will partner with Indiana University and other key bioscience organizations in the state to make significant advances in human health and help make Indiana a global leader in bioscience innovation by establishing the IU Launch Accelerator for Biosciences, known as IU LAB, at the 16 Tech Innovation District in Indianapolis. 

“IU LAB will play a critical role in advancing life and biosciences innovation to address our state’s most critical health challenges,” said Rachel Patzer, PhD, MPH, Regenstrief president and CEO. Through its efforts to translate research into practice, this partnership will lead to better health outcomes and improved health care across Indiana.”  

View the complete press release on Indiana University’s webpage 

Partners

Related News

Public Health Emergency Surveillance System celebrates 20 years of service

Public Health Emergency Surveillance System celebrates 20 years of service

Indiana’s syndromic surveillance system for public health surpasses the typical lifespan of public health technical initiatives Created by Regenstrief

Kosali Simon, PhD

Research team to study critical aspects of Alzheimer’s and dementia healthcare delivery

Kosali Simon, PhD, M.A., a professor with the Paul H. O’Neill School of Public and Environmental Affairs and a

Sarah Wiehe, MD

Regenstrief researcher on author list for 1 of JAMA’s 2024 most viewed papers

A paper co-authored by Regenstrief Research Scientist Sarah Wiehe, M.D., M.P.H., as a member of the U.S. Preventive Services

Marianne Matthias, PhD

Study to address health inequities in chronic pain treatment moves to full clinical trial

INDIANAPOLIS – A successful pilot study to address health inequities related to chronic pain and depression has received notification